AKT1 and lung cancer: It has a strong potential as an anticancer agent because of its ability to induce G1 arrest and apoptosis to inhibit KRAS mutant lung cancer cell growth by disrupting oncogenic KRAS-mediated RAF/MEK/ERK and RAF/PI3K/AKT signaling pathway.